Insider trades
Watts Ryan J., CEO of Denali Therapeutics DNLI, has filed 0 purchases and 20 sales on the open market. Over the past 12 months that comes to a net sale of $580.8K. The latest trade was on 01/06.
Watts Ryan J.
President and CEO
- Company
- Denali Therapeutics DNLI
- First filing
- 23/01/05
- Trades
- 48 trades
- Buys / sales
- 0 / 20
- 12-month net buying
- −$580.8K
- Last trade
- 01/06
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/06 | 01/08 | 35,198 sh | $16.50 | $580,767 | −10.6% | |
| Open-market sale10b5-1 plan | 25/07/09 | 25/07/11 | 495,282 sh | $15.00 | $7,429,230 | −66.2% | |
DNLI | Open-market sale | 25/01/06–25/01/07 | 25/01/08 | 36,916 sh2 trades | $20.34avg. | $750,955.02 | −12.7% |
| Open-market sale10b5-1 plan | 24/10/18 | 24/10/22 | 40,000 sh | $27.69 | $1,107,600 | −14.5% | |
| Open-market sale | 24/08/20 | 24/08/22 | 2,260 sh | $23.79 | $53,765.4 | −0.9% | |
| Open-market sale | 24/02/13 | 24/02/15 | 9,589 sh | $17.29 | $165,793.81 | −3.9% | |
| Open-market sale | 24/01/09 | 24/01/11 | 7,818 sh | $19.78 | $154,640.04 | −0.3% | |
| Open-market sale | 24/01/05 | 24/01/09 | 17,483 sh | $19.43 | $339,694.69 | −0.8% | |
| Open-market sale | 23/08/21 | 23/08/23 | 2,309 sh | $22.59 | $52,160.31 | −0.1% | |
| Open-market sale | 23/08/10 | 23/08/14 | 2,526 sh | $25.03 | $63,225.78 | −0.1% | |
| Open-market sale | 23/06/16 | 23/06/20 | 50,000 sh | $31.40 | $1,570,000 | −2.2% | |
DNLI | Open-market sale | 23/04/20–23/04/21 | 23/04/24 | 25,000 sh2 trades | $25.15avg. | $628,720 | −1.1% |
DNLI | Open-market sale | 23/02/13 | 23/02/15 | 33,815 sh2 trades | $30.08avg. | $1,017,243.35 | −1.5% |
DNLI | Open-market sale | 23/02/09–23/02/10 | 23/02/13 | 28,433 sh2 trades | $29.28avg. | $832,515.47 | −1.3% |
| Open-market sale | 23/01/05 | 23/01/09 | 4,800 sh | $28.44 | $136,512 | −0.2% | |
| Open-market sale | 23/01/04 | 23/01/05 | 5,029 sh | $28.73 | $144,483.17 | −0.2% |